🇺🇸 FDA
Company

4D

4D Molecular Therapeutics

FDMT biotech USA

Quick answer

4D is a biotech company (FDMT) headquartered in EMERYVILLE, CA, USA with 18 tracked pipeline programs.

Pipeline (18)

project

4D-150 IVT (3E10 vg/eye)

Macular Neovascularization Secondary to Age-Related Macular Degeneration

Phase 3 · mab · active

1 trials project

4D-150 IVT (3E10 vg/eye)

Neovascular Age-Related Macular Degeneration (nAMD)

Phase 3 · mab · active

1 trials project

4D-125 IVT Injection

X-Linked Retinitis Pigmentosa

Phase 2 · mab · active

1 trials project

4D-150 IVT

Diabetic Macular Edema

Phase 2 · mab · active

1 trials project

4D-150 IVT

Neovascular (Wet) Age-Related Macular Degeneration

Phase 2 · mab · active

1 trials project

4D-310

Fabry Disease

Phase 2 · mab · active

2 trials project

4D-710

Cystic Fibrosis Lung

Phase 2 · mab · active

1 trials project

Blautix

Irritable Bowel Syndrome

Phase 2 · mab · completed

1 trials project

MRx-4DP0004

COVID-19

Phase 2 · small_molecule · terminated

1 trials project

MRx0518

Urothelial Carcinoma

Phase 2 · small_molecule · terminated

1 trials project

MRx0518

Oncology

Phase 2 · small_molecule · terminated

1 trials project

4D-110

Choroideremia

Phase 1 · mab · active

1 trials project

MRx-4DP0004

Asthma

Phase 1 · small_molecule · terminated

1 trials project

MRx0029

Idiopathic Parkinson Disease

Phase 1 · mab · terminated

1 trials project

MRx0518

Pancreatic Cancer

Phase 1 · small_molecule · terminated

1 trials project

MRx0518 Capsules

Melanoma

Phase 1 · small_molecule · active

1 trials project

Training with 4D Motion Capture Device

Stroke

Phase 1 · other · completed

1 trials project

4D

Dietary Supplementation

Unknown · other · completed

1 trials

Patents (8)

patent

US 11840704

Adeno-associated virus variant capsids and methods of use thereof

Expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11807868

Adeno-associated variants, formulations and methods for pulmonary delivery

Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11766487

Treatments for retinal disease

Expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11766489

Adeno-associated virus variant capsids and use for inhibiting angiogenesis

Expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11576983

Treatments for retinal disease

Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11524081

Codon optimized REP1 genes and uses thereof

Expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11499166

Adeno-associated variants, formulations and methods for pulmonary delivery

Expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11419949

Adeno-associated virus variant capsids and methods of use thereof

Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)